Erik Larsson
1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
- Albumin infusion rate and plasma volume expansion : A randomized clinical trial in postoperative patients after major surgery
- 2018
-
Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours
Jönsson, L. LU ; Stenvall, A. LU ; Mattsson, E. ; Larsson, E. LU ; Sundlöv, A. LU
; Ohlsson, T.
and Hindorf, C.
LU
(2018)
In EJNMMI Physics
5(1).
Mark
- 2016
- Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide 177Lu Compared to Alpha Particles and Gamma Rays.
- The importance of albumin infusion rate for plasma volume expansion following major abdominal surgery - AIR: Study protocol for a randomised controlled trial
- Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays
- Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
- 2015
-
Long-term retention of 177Lu/177mLu-Dotatate in patients investigated by gamma spectrometry and gamma camera imaging.
Sjögreen Gleisner, Katarina LU ; Brolin, Gustav LU ; Sundlöv, Anna LU
; Mjekiqi, Edita
; Östlund, Karl
LU
; Tennvall, Jan
LU
and Larsson, Erik
LU
(2015)
In Journal of Nuclear Medicine
56(7).
p.976-984
Mark
- 2014
- 188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment.
- A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation.